Rinvoq ER 45 MG tablet UU 28S
Ended Awarded Last action
- Contract number
- SPE2DR26F1AG2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,549
Award facts
- Contract value 100% obligated
- $15,548.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order contract by the Defense Logistics Agency (DLA) on January 20, 2026, for the supply of RINVOQ ER 45 mg tablets in packages of 28 units. This is a firm fixed-price, competitively awarded delivery order with a ceiling value of $15,548.54 and an ultimate completion date of January 21, 2026. The contract carries no set-aside designation, reflecting open and full competition. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with the DLA Troop Support Medical, a single-award IDC valued at up to $999,999,999.00 through December 2026. This comprehensive pharmaceutical prime vendor contract enables the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally, including the Defense Health Agency, U.S. Coast Guard, and other federal medical systems. RINVOQ ER, a JAK inhibitor used in the treatment of rheumatoid arthritis and other inflammatory conditions, exemplifies the specialized pharmaceutical products delivered through this strategic contract vehicle to serve federal healthcare needs.
Quick answers
Who was awarded contract SPE2DR26F1AG2?
SPE2DR26F1AG2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F1AG2 worth?
The government has obligated $15,549 on SPE2DR26F1AG2.
Is contract SPE2DR26F1AG2 an order under another contract?
Yes. SPE2DR26F1AG2 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AG2 competed?
The extent of competition for SPE2DR26F1AG2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award